N.J. Admin. Code § 13:39-11.19 - Stability and sterility criteria and beyond-use dating
(a) For
purposes of this section, stability means the extent to which a preparation
retains, within specified limits and throughout its period of storage and use,
the same properties and characteristics that it possessed at the time of
compounding.
(b) In the absence of
supporting valid scientific sterility testing and stability information that is
directly applicable to specific preparations, the following dates and times for
storage and initiation of administration of the compounded sterile preparations
shall apply, according to the assigned risk level of the preparation, unless
the manufacturer's package indicates a different stability time:
1. For low-risk level compounded sterile
preparations, in the absence of passing a sterility test:
i. Administration shall begin within 48 hours
when the preparation is stored at controlled room temperature (20 degrees
Celsius to 25 degrees Celsius);
ii.
Administration shall begin within 14 days when the preparation is stored at
cold temperatures (two degrees Celsius to eight degrees Celsius);
iii. Administration shall begin within 45
days when the preparation is stored in a solid frozen state (-20 degrees
Celsius); and
iv. For products
prepared in an airflow workbench not located in a buffer area in accordance
with N.J.A.C. 13:39-11.10,
administration shall begin within 12 hours or less of preparation;
2. For medium-risk level
compounded sterile preparations, in the absence of passing a sterility test:
i. Administration shall begin within 30 hours
when the preparation is stored at controlled room temperature (20 degrees
Celsius to 25 degrees Celsius);
ii.
Administration shall begin within nine days when the preparation is stored at
cold temperatures (two degrees Celsius to eight degrees Celsius); and
iii. Administration shall begin within 45
days when the preparation is stored in a solid frozen state (-20 degrees
Celsius);
3. For
high-risk level compounded sterile preparations, in the absence of passing a
sterility test:
i. Administration shall begin
within 24 hours when the preparation is stored at controlled room temperature
(20 degrees Celsius to 25 degrees Celsius);
ii. Administration shall begin within three
days when the preparation is stored at cold temperatures (two degrees Celsius
to eight degrees Celsius); and
iii.
Administration shall begin within 45 days when the preparation is stored in a
solid frozen state (-20 degrees Celsius); and
4. For immediate use compounded sterile
preparations, administration shall begin no less than one hour following the
start of preparing the compounded sterile preparation.
(c) The administration dates and times
established in (b) above shall not be exceeded or extended for compounded
sterile preparations without verifiable supporting valid scientific sterility
and stability information that is directly applicable to the specific
preparation or compound.
(d) A
pharmacist shall determine the beyond-use date for a compounded sterile
preparation consistent with (b) above and assign an appropriate discard-after
date for the compounded sterile preparation. The discard-after date shall
appear on the label consistent with the requirements of
N.J.A.C.
13:39-11.21.
(e) Opened or needle-punctured single-dose
containers of sterile products (for example, bags, bottles, syringes, and
vials) used in the compounding of sterile preparations for immediate use in an
institutional pharmacy pursuant to
N.J.A.C.
13:39-11.11, shall be used within one hour if
opened in worse than ISO Class 5 air quality, and any remaining contents shall
be discarded.
(f) Single-dose vials
used in the compounding of sterile preparations exposed to ISO Class 5 or
cleaner air quality may be used up to six hours after initial
puncture.
(g) Opened single-dose
ampules used in the compounding of sterile preparations shall not be stored for
any period of time.
(h) Opened or
needle-punctured multiple-dose vials used in the compounding of sterile
preparations shall be used within 28 days after initially entering the vial,
unless otherwise specified by the manufacturer.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.